- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Leukemia, Myelomonocytic, Juvenile
Medical specialists from France tagged as investigators in clinical trials studying Leukemia, Myelomonocytic, Juvenile
Total 24 results
-
Alice GARNIER, MDSeen in:
- Nantes, Chu Hotel Dieu
Trials:- NCT05226455 (Principal Investigator)
- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
Conditions: -
Aspasia STAMATOULLAS, MDSeen in:
- Rouen, Centre Henri Becquerel
Trials:- NCT05226455 (Principal Investigator)
- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
Conditions: -
Caroline CHARLIER-WOERTHER, MD, PhDSeen in:
- Villejuif, Gustave Roussy Institut
Trials:- NCT04953312 (Sub-Investigator)
-
Cherifa CHEURFA, MDSeen in:
- Villejuif, Gustave Roussy Institut
Trials:- NCT04953312 (Sub-Investigator)
-
Christophe WILLEKENS, MDSeen in:
- Villejuif, Institut Gustave Roussy
Trials:- NCT05768711 (Principal Investigator)
Conditions: -
Delphine LEBON, MDSeen in:
- Amiens, CHU d'Amiens
Trials:- NCT05768711 (Principal Investigator)
Conditions: -
Didier BOUSCARY, PhDSeen in:
- Villejuif, Gustave Roussy Institut
Trials:- NCT04953312 (Sub-Investigator)
-
Emmanuel GYAN, MD/PhDSeen in:
- Tours, CHU de Tours - Hôpital Bretonneau
Trials:- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
Franciane PAUL, MDSeen in:
- Montpellier, CHU DE MONTPELLIER - Hopital Saint Eloi
- Montpellier, CHU Saint Eloi
Trials:- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
Frédéric PENE, MD, PhDSeen in:
- Villejuif, Gustave Roussy Institut
Trials:- NCT04953312 (Sub-Investigator)
-
Jacques DELAUNAY, MDSeen in:
- Nantes, Hôpital privé du Confluent SAS
Trials:- NCT05768711 (Principal Investigator)
Conditions: -
Jose Miguel TORREGROSA DIAZ, MDSeen in:
- Poitiers, CHU de Poitiers
- Poitiers, CHU de Poitiers/Pôle de cancérologie - secteur tertiaire-
Trials:- NCT03503409 (Principal Investigator)
- NCT03223961 (Principal Investigator)
- NCT04827719 (Principal Investigator)
- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
Maël HEIBLIG, MDSeen in:
- Pierre-Bénite, Centre Hospitalier Lyon Sud
Trials:- NCT05768711 (Principal Investigator)
Conditions: -
Marie-Pierre GOURIN, MDSeen in:
- Limoges, CHRU de Limoges
- Limoges, CHU de Limoges - Hôpital Dupuytren
Trials:- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
Norbert VEY, MD/PhDSeen in:
- Marseille, Institut Paoli Calmettes
Trials:- NCT05768711 (Principal Investigator)
Conditions: -
Raphaël ITZYKSON, MD/PhDSeen in:
- Paris, Hôpital Saint louis
Trials:- NCT05768711 (Principal Investigator)
Conditions: -
Rudy BIRSEN, MDSeen in:
- Paris, Hôpital Cochin
Trials:- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
Sophie PARK, MD/PhDSeen in:
- Grenoble, CHU de Grenoble
Trials:- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
Stanislas NIMUBONA, MDSeen in:
- Rennes, CHU Pontchaillou
- Rennes, Hôpital Pontchaillou
Trials:- NCT03223961 (Principal Investigator)
- NCT04827719 (Principal Investigator)
- NCT05768711 (Principal Investigator)
-
Sylvain THEPOT, MDSeen in:
- Angers, CHU d'Angers
- Angers, Chu Angers
Trials:- NCT04905407 (Principal Investigator)
- NCT05226455 (Principal Investigator)
- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
Tali-Anne SZWEBEL, MDSeen in:
- Villejuif, Gustave Roussy Institut
Trials:- NCT04953312 (Sub-Investigator)
-
Thibault COMONT, MDSeen in:
- Toulouse, IUCT Oncopole
Trials:- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
Thomas CLUZEAU, MD/PhDSeen in:
- Nice, Hôpital Archet 1
Trials:- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
-
Thorsten BRAUN, MD/PhDSeen in:
- Bobigny, Hôpital Avicenne
Trials:- NCT05768711 (Principal Investigator)
- NCT05782127 (Principal Investigator)
Clinical Trials on Leukemia, Myelomonocytic, Juvenile
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedJuvenile Myelomonocytic LeukemiaUnited States, Canada, Australia, New Zealand
-
National Cancer Institute (NCI)CompletedJuvenile Myelomonocytic LeukemiaUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedJuvenile Myelomonocytic LeukemiaUnited States
-
Masonic Cancer Center, University of MinnesotaTerminated
-
Gustave Roussy, Cancer Campus, Grand ParisRecruitingMyelomonocytic LeukemiaFrance
-
University of UtahCelgeneCompletedChronic Myelomonocytic LeukemiaUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieCelgene CorporationUnknownChronic Myelomonocytic LeukemiaAustria
-
M.D. Anderson Cancer CenterAmgenTerminated
-
Columbia UniversityCompletedJuvenile Myelomonocytic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
Groupe Francophone des MyelodysplasiesJanssen-Cilag Ltd.CompletedChronic Myelomonocytic LeukemiaFrance